🇺🇸 FDA
Patent

US 7179815

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61KA61K31/513A61P

Quick answer

US patent 7179815 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/513, A61P, A61P1/04, A61P13/08